The first one holds up reasonably well. The other two don’t.<\/p>\n
The second one is the important failure, because it’s the one that can cost a dog treatable time. Canine cognitive dysfunction syndrome is a diagnosis of exclusion<\/strong> \u2014 there is no blood test, no scan, no questionnaire that says “yes, it’s dementia.” Every single one of those signs has other causes that have to be ruled out first. Calling it “just old age” hides treatable disease. So does calling it “just dementia.”<\/p>\n So this is the honest version. What the syndrome is, how common it actually is, the long list a veterinarian has to work through before landing on it, what the night pacing really means, and which parts of the standard advice have real evidence behind them and which don’t.<\/p>\n Photo: Rufina Rusakova \/ Pexels<\/em><\/p>\n Canine cognitive dysfunction syndrome \u2014 CCDS, or CDS in older writing \u2014 is described in the clinical literature as “a chronic, progressive, age-associated neurodegenerative syndrome, characterized by cognitive and behavioral changes that affect daily life to varying degrees.” It generally starts from around 8 years of age<\/strong>.<\/p>\n The comparison to human Alzheimer’s disease isn’t just a marketing metaphor. The neuropathology genuinely overlaps: amyloid-beta deposition and tau protein changes<\/strong> show up in affected dogs’ brains.<\/p>\n But I’d say analogous to<\/em>, not identical to<\/em>. That distinction matters more than it sounds, because it’s the gap where a lot of confident, unsupported advice grows.<\/p>\n The behavioral domains affected are grouped under the acronym DISHAA<\/strong>: disorientation, altered interactions, sleep\u2013wake disruption, house soiling and lost learning, activity changes, and anxiety. You’ll also see DISHA<\/strong> (five letters, still used by Ohio State) and DISHAAL<\/strong> (adding “loss of learned behaviors”). All three are current in the literature. Don’t let the alphabet soup distract you \u2014 the observations underneath are the same.<\/p>\n This is the part that reframed the whole subject for me.<\/p>\n Prevalence climbs steeply with age. In an owner questionnaire study of 1,079 dogs<\/strong>, presumptive advanced cognitive dysfunction looked like this:<\/p>\n Other estimates vary a lot depending on the age band and the measuring instrument \u2014 published figures range roughly from 14.2% to 68%<\/strong>, with one clinical journal citing a spread of 22.5% to 73.5% across studies. The AVMA’s coverage of the newest guidelines puts it at roughly 60% of dogs aged 15 and older showing signs, with about 20% experiencing severe disease.<\/strong><\/p>\n Pick whichever number you like. They all say the same thing: this is not rare.<\/p>\n And now the number that actually bothered me.<\/p>\n In a survey of around 500 dogs aged 8 to 19, prevalence was 14.2% \u2014 but only 1.9% had ever been diagnosed by a veterinarian.<\/strong> In the 1,079-dog dataset, only 1.8% of the cognitively impaired dogs had a prior diagnosis on record.<\/p>\n The gap has two sides, and I think it’s only fair to show both.<\/p>\n On the owner side: one survey found that 75% of dogs had at least one behavioral change consistent with cognitive dysfunction, but only 12% of owners had mentioned that change to their veterinarian.<\/strong> We assume it’s aging, so we don’t bring it up.<\/p>\n On the veterinary side, there’s a national survey of veterinary professionals \u2014 in Australia, not the US<\/strong>, so read the percentages as a signal rather than a local statistic. In that sample, 73% of veterinarians diagnosed the condition only “a few times per year or less,”<\/strong> even though prevalence figures suggest they should be meeting a case every four to ten days. Diagnosis was based on personal experience in 37% of cases and on excluding other diseases in 34%, while only 18% used a validated scale.<\/strong> Meanwhile 67% agreed they diagnosed it confidently.<\/p>\n So the practical takeaway isn’t complicated.<\/p>\n Bring it up at the appointment. Bring notes.<\/p>\n This is the half of the story the popular version skips entirely, and it’s the half I’d want a friend to read.<\/p>\n There is no confirmatory test for CCDS. Diagnosis requires DISHAA-type signs that cannot be explained by a medical disease<\/strong> \u2014 which means the other diseases have to be looked for and excluded. The AVMA’s summary of the 2026 guidelines puts it plainly: “Many conditions, including pain, infections, metabolic disease and neoplasia, can produce similar behavioral signs and must be ruled out.”<\/p>\n Photo: Cara Denison \/ Pexels<\/em><\/p>\n Look at that last-but-one row for a second, because it’s the detail I keep coming back to.<\/p>\n Benzodiazepines and anticonvulsants appear on the rule-out list as causes of confusion in senior dogs \u2014 and they also appear on the list of drugs sometimes used to manage the night-time and anxiety components.<\/strong> The same drug class can be the cause or the treatment depending on the dog. That is exactly why this belongs to a veterinarian and not to an article.<\/p>\n There’s hard evidence for this, not just clinical caution.<\/p>\n A cross-sectional study of 804 dogs<\/strong> measured how much medical conditions track with cognitive dysfunction scores. Musculoskeletal\u2013neurological signs correlated at r = 0.69<\/strong> with cognitive scores; overall health score correlated at r = 0.71. Metabolic conditions came in at 0.36, digestive at 0.32, dermatological at 0.27.<\/p>\n The authors’ conclusion is worth quoting directly: “if veterinarians suspect a patient may be suffering from CCDS, this study highlights the need to ensure that the patient is screened for other conditions, particularly those that are painful, that might be confusing the clinical picture.”<\/p>\n In other words, a painful dog can score like a demented dog.<\/p>\n And then there’s the night-restlessness study, which I want to present in both directions because it’s genuinely two-sided. Researchers looked at dogs with naturally occurring osteoarthritis pain: 60 dogs untreated for two weeks then two weeks on an NSAID, plus a smaller masked placebo-controlled crossover arm.<\/p>\n The owner-rated<\/strong> night-time restlessness score improved on the NSAID (p = 0.001<\/strong> against baseline, p = 0.049<\/strong> against placebo). The accelerometer<\/strong> disagreed \u2014 night activity counts showed no significant difference between the baseline period and the treatment period.<\/p>\n So which is true? Honestly, both readings deserve to survive.<\/p>\n The defensible statement is that arthritis pain is a documented contributor to night-time restlessness, and it is treatable. The indefensible statement would be “pain medication fixes night pacing.” The objective movement data didn’t back that up.<\/p>\n If you bring this to your veterinarian, the workup described in the clinical literature generally involves history-taking, then physical, orthopedic, neurologic and ophthalmologic examination<\/strong>, a complete blood count, serum chemistry, thyroid (T4) and urinalysis<\/strong>, and a blood pressure measurement<\/strong>. Chest radiographs or abdominal ultrasound get added where indicated, along with a structured owner questionnaire.<\/p>\n MRI and cerebrospinal fluid analysis exist for advanced or atypical cases, to exclude structural lesions, inflammation, or tumors. They are not<\/strong> a routine step for a typical senior dog, and I don’t want anyone walking into an appointment expecting one.<\/p>\n I won’t publish a price. I looked, and the figures I found came from individual clinic pages rather than any national survey, so quoting one would be inventing precision. What I can say fairly: initial behavior consultations tend to run several hundred dollars and vary widely by region, so ask when you book.<\/p>\n The DISHAA framework was developed by veterinary behaviorist Dr. Gary Landsberg, and the printable version is distributed by a pet-food company’s institute. It’s clinically standard and used by university and professional sources \u2014 I just think you deserve to know who prints the handout.<\/p>\n Here’s what the letters cover:<\/p>\n Now the part where I have to disappoint anyone hoping for a score-yourself quiz.<\/p>\n I’m not publishing a cut-off table, and here’s why.<\/strong> The published scoring bands for DISHAA conflict across sources. Worse, when researchers compared the three validated questionnaires head to head \u2014 CADES, CCAS and CCDR \u2014 the tools disagreed with each other.<\/strong> One classified 35% of dogs as mildly impaired and 21% as moderate; another put 49% in mild; a third called 67% of the same population normal. Agreement between them was only moderate, and the authors concluded that “the choice of screening questionnaire impacts the evaluation of cognitive status and severity of CCD.”<\/p>\n If the professional instruments can’t agree, a number you calculate on your couch isn’t a diagnosis.<\/p>\n What the list is<\/em> good for is observation. Which signs, how often, at what time of day, since when. Write that down, and if you can, take short phone videos of the behavior. That’s the material a veterinarian can actually use.<\/p>\n Cornell’s canine health center says it directly: the sleep disruption “is often the first sign that families notice. Your senior dog is now up and walking around in the middle of the night.”<\/p>\n And it isn’t only a subjective impression. A polysomnographic study of 28 senior dogs<\/strong> (mean age 13.25 years) recorded actual sleep and found that dogs with higher dementia scores spent less time in both NREM and REM sleep<\/strong>, with a longer latency to fall into NREM. The researchers concluded that polysomnography “can detect sleep-wakefulness cycle changes associated with dementia,” and drew the parallel to the sleep fragmentation seen in human Alzheimer’s disease.<\/p>\n So the 3 a.m. wandering in the original premise is real, measurable, and an early feature. The correction isn’t about whether it happens.<\/p>\n It’s about what’s causing it in your<\/em> dog.<\/p>\n Everything in this section is a conversation to have with your veterinarian. None of it is a home protocol, and I’d be uncomfortable if it read like one.<\/p>\n This is the lowest-risk, most immediately usable category, and it comes straight from university veterinary sources.<\/p>\n Cornell also mentions acupuncture, laser treatment, underwater treadmill work and swimming for senior dogs. I’ll be straight with you: I found no cognitive efficacy data for any of them. File them under comfort and mobility support, not dementia treatment.<\/p>\n Photo: Max Vakhtbovych \/ Pexels<\/em><\/p>\n Here’s where I have to walk back my own belief.<\/p>\n The study everyone is referencing when they say nose work “stimulates brain cells” is Duranton and Horowitz, 2019. It involved 20 pet dogs<\/strong> at least a year old. Ten did nosework, ten did heelwork, for two weeks<\/strong>. The outcome measure was a cognitive bias test<\/strong> \u2014 dogs learned that one bowl location always had food and another never did, then an empty bowl went in an ambiguous middle spot, and the researchers timed how quickly each dog approached it.<\/p>\n The nosework dogs approached the ambiguous bowl faster. That was interpreted as increased optimism. The authors framed it in welfare terms: sniffing lets a dog express a natural behavior and make active choices, and both matter for animal welfare.<\/p>\n Read that list again and notice what isn’t in it.<\/p>\n There were no dogs with cognitive dysfunction in the study. There was no measurement of brain cells of any kind.<\/strong> It’s a welfare finding in 20 healthy dogs over two weeks, and stretching it into neurogenesis is not something the data can carry.<\/p>\n The neuron-preservation result people are half-remembering comes from somewhere else \u2014 a two-year laboratory beagle program<\/strong> where environmental enrichment protected against neuronal loss in the hippocampus, and where enrichment was paired with a therapeutic diet. Structured, long-term, in a research colony. Not a snuffle mat.<\/p>\n And one more caution I didn’t expect to find. Olfactory decline is itself a sign of cognitive dysfunction<\/strong> \u2014 the CCDR questionnaire includes olfaction items. So scent games can get harder as the disease advances, and a dog who stops solving the snuffle mat isn’t an owner failure. It may be the illness showing itself.<\/p>\n Does that mean skip the sniffing? Not at all.<\/p>\n Scent games, snuffle mats, food puzzles and slow sniff-walks are recommended by Cornell and by clinical practice sources as senior enrichment. They’re cheap, low-risk, and adaptable to a dog with bad hips \u2014 adjusted for the dog’s endurance, as the clinical guidance puts it. Enrichment combined with<\/em> a therapeutic diet is the pairing with the best evidence for slowing decline.<\/p>\n Keep the activity. Drop the mechanism claim.<\/p>\n Photo: Karl Byron \/ Pexels<\/em><\/p>\n This is the correction I’d most want to hand back to my past self.<\/p>\n No source frames antioxidant or omega-3 supplementation as a “must.”<\/strong> And the trial evidence people cite for it doesn’t attach to over-the-counter supplements at all. It attaches to complete veterinary therapeutic diets<\/strong> \u2014 which are a different product category, formulated as the whole diet, obtained through a veterinarian.<\/p>\n There are two main bodies of evidence, and both come with limits.<\/p>\n The antioxidant diet study<\/strong> used 48 aged beagles (9 to 12 years) split across four groups \u2014 control or antioxidant food, control or enriched environment \u2014 over two years. The highest cognitive scores went to the dogs receiving both<\/strong> the antioxidant diet and the added enrichment. Dietary therapy reduced beta-amyloid pathology and reactive oxygen species while improving mitochondrial function. The limits: laboratory beagles in a controlled colony, a complete formulated diet rather than a pill, and a design about slowing decline in aging dogs \u2014 not rescuing a dog already pacing at 3 a.m.<\/p>\n The MCT diet trial<\/strong> (Pan et al., 2018) enrolled 87 dogs, 29 per group<\/strong>, over 90 days<\/strong>: a control diet, a 6.5% medium-chain triglyceride diet with a “brain protection blend,” and a 9% MCT version. The 6.5% diet showed significant improvement (p < 0.05) in all six<\/strong> cognitive dysfunction categories by day 90.<\/p>\n Now the parts that usually get left out.<\/p>\n The study was entirely funded by Nestl\u00e9 Purina Research, and several authors are Purina employees.<\/strong> Outcomes were, in the authors’ own words, “entirely dependent on pet owners’ input\u2026 which could be subjective.” And the control diet also improved 4 of the 6 categories<\/strong> \u2014 failing only on disorientation and altered social interaction. That’s a visible placebo effect sitting right there in the results table.<\/p>\n I don’t think that erases the finding. I think it sizes it correctly.<\/p>\n As for the supplement aisle \u2014 SAMe, phosphatidylserine, ginkgo biloba, and the multi-ingredient blends \u2014 clinical reviews name them as commonly used, with no independent efficacy data presented<\/strong> for the individual ingredients. For omega-3 and DHA on their own, the WSAVA-affiliated review describes standalone canine data as “limited.”<\/strong> They appear as part of combination therapies that showed benefit, which is not the same claim.<\/p>\n One frequently repeated DHA trial statistic circulates widely online. I’m deliberately leaving it out, because it traces back to a supplement manufacturer’s press release rather than a peer-reviewed source, and I didn’t want a marketing number sitting in the middle of this section.<\/p>\n In that Australian veterinary survey, 66% of respondents recommend food supplements.<\/strong> Common practice. Not the same thing as strong evidence. Both facts can be true at once, and your veterinarian is the person to weigh them for your specific dog.<\/p>\n Selegiline<\/strong> is the only FDA-approved drug for canine cognitive dysfunction and the only one licensed for it in North America. It’s a selective MAO-B inhibitor that increases catecholamines and reduces free radicals in the cortex and hippocampus; Cornell describes it as protecting nerve cells and enhancing dopamine in the brain. Clinical trials report improvement in sleeping, house-training and activity.<\/p>\n Expectations, set honestly: it doesn’t cure anything, it doesn’t work for every dog, and onset can take anywhere from four to twelve weeks<\/strong>.<\/p>\n Other drugs appear in clinical sources as adjuncts for the anxiety and night-time components \u2014 SSRIs, tricyclic antidepressants, trazodone, gabapentin, clonidine, benzodiazepines. Melatonin<\/strong> gets mentioned for night-time wandering, but Cornell notes plainly that it lacks robust evidence<\/strong>.<\/p>\n You’ll notice there isn’t a single dose anywhere in this article. That’s on purpose. These are prescription decisions made for an individual animal after the rule-out work is done, and I’d be doing you real harm by putting numbers here.<\/p>\n In 2026, a CCDS Working Group published the first dedicated guidelines for diagnosing and monitoring the condition, in JAVMA. I want to be upfront about sourcing: the full paper was behind a paywall for this research, so what follows comes via the AVMA’s own news summary of the guidelines<\/strong>, not from reading the paper in full.<\/p>\n Per that summary, the recommendations are:<\/p>\n The routing for most families is simple: start with your primary-care veterinarian, who does the rule-out workup and can refer onward to a board-certified veterinary behaviorist (DACVB)<\/strong> or a veterinary neurologist for complex cases. There are very few DACVBs in the country, so referral is generally reserved for cases that need it.<\/p>\n Photo: Mikhail Nilov \/ Pexels<\/em><\/p>\n I’ll include this because the research includes it, and leaving it out would make this article dishonest.<\/p>\n Sixteen percent of guardians of dogs with cognitive dysfunction reach clinically significant caregiver burden.<\/strong> The behaviors they name as hardest to live with are night-time disturbance, barking, house soiling, aggression and separation issues \u2014 with night-time disturbance leading the list. Burden was associated with the severity of the condition, where the dog sleeps, household size, employment, the ages of dog and guardian, and whether the dog was on medication. Unpredictable symptoms cost the most time, especially in households with children or multiple pets.<\/p>\n Anticipatory grief is documented too \u2014 owners describing mourning the gradual loss of their dog before death occurs.<\/p>\n I’m not going to tell you what to do with any of that, and I want to say so explicitly. Caregiver burden has been correlated with consideration of euthanasia in aged and seriously ill companion animals, and that is not a subject an article should have opinions about. What’s fair to say is that the burden is measured, common, and legitimate; that quality-of-life assessment and end-of-life conversations are a normal part of veterinary care for this diagnosis; and that your veterinarian \u2014 or a hospice and palliative practice, where one is available \u2014 is the right place to have them.<\/p>\n One practical note from the same research, offered gently: where the dog sleeps was an associated factor.<\/strong> That’s a concrete, discussable variable. Not a moral one.<\/p>\n Cognitive dysfunction is slow<\/strong>. It develops over months and years. That fact is itself a diagnostic tool, because it means anything abrupt deserves a different reaction.<\/p>\n Contact a veterinarian promptly \u2014 not at the next routine visit \u2014 for any of these:<\/p>\n Gradual onset over months fits this diagnosis. Sudden onset does not.<\/p>\n If I had to compress everything above into one sentence, it wouldn’t be about supplements or snuffle mats.<\/p>\n It would be this: the wall-staring and the night pacing are worth taking seriously precisely because they might not be dementia.<\/p>\n That’s the thing I got backwards. I thought recognizing the signs was the finish line, when recognizing them is only the reason to go looking \u2014 for the sore hip, the bad tooth, the thyroid, the blood pressure, the medication that stopped agreeing with an older body. Some of those are fixable. All of them are worth excluding before anyone settles on the answer that can’t be fixed.<\/p>\n And if it does turn out to be cognitive dysfunction, that’s not the end of the usefulness either. There’s a routine to make predictable, a hallway to light, an evening walk to add, a diet to discuss, a drug to consider, and a whole lot of sniffing to do \u2014 not because it regrows brain cells, but because a dog who gets to use his nose gets to be a dog a while longer.<\/p>\n Which, when I sit with it, was always the actual goal.<\/p>\n Veterinary disclaimer.<\/strong> This article is general information about animal health, not veterinary advice, and it does not replace an examination by a licensed veterinarian. Canine cognitive dysfunction syndrome is a diagnosis of exclusion that can only be made by a veterinarian after other medical causes have been investigated. No dose or dosing schedule appears here by design. Do not start, stop, or change any diet, supplement, or medication for your dog based on this article \u2014 every item mentioned, including therapeutic diets and over-the-counter supplements, is a decision to make with your veterinarian. If your dog is showing any of the signs described here, book an appointment and bring your written notes and videos.<\/p>\n Canine cognitive dysfunction is common and rarely diagnosed. What the signs mean, what a vet must rule out first, and what care the evidence supports.<\/p>\n","protected":false},"author":1,"featured_media":1491,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[12],"tags":[474,478,475,477,476],"class_list":["post-1499","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pet-health","tag-canine-cognitive-dysfunction","tag-dishaa","tag-dog-dementia","tag-night-pacing-in-dogs","tag-senior-dog-care"],"_links":{"self":[{"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/posts\/1499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/comments?post=1499"}],"version-history":[{"count":0,"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/posts\/1499\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/media\/1491"}],"wp:attachment":[{"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/media?parent=1499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/categories?post=1499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wewellinfo.com\/us\/wp-json\/wp\/v2\/tags?post=1499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What canine cognitive dysfunction syndrome actually is<\/h2>\n
How common is it? Common enough that your vet should be seeing it weekly<\/h2>\n
\n\n
\n \nAge band<\/th>\n Prevalence<\/th>\n<\/tr>\n<\/thead>\n \n 8 to under 11 years<\/td>\n 8.1%<\/strong><\/td>\n<\/tr>\n \n 11 to under 13 years<\/td>\n 18.8%<\/strong><\/td>\n<\/tr>\n \n 13 to under 15 years<\/td>\n 45.3%<\/strong><\/td>\n<\/tr>\n \n 15 to under 17 years<\/td>\n 67.3%<\/strong><\/td>\n<\/tr>\n \n Over 17 years<\/td>\n 80%<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n ![\"Chart](\"https:\/\/wewellinfo.com\/us\/wp-content\/uploads\/2026\/08\/body-1-15.png\")
<\/p>\nBefore “dementia,” here’s what has to be ruled out<\/h2>\n
![\"An](\"https:\/\/wewellinfo.com\/us\/wp-content\/uploads\/2026\/08\/body-2-14.jpg\")
<\/p>\nThe rule-out list<\/h3>\n
\n\n
\n \nCategory<\/th>\n What has to be considered<\/th>\n<\/tr>\n<\/thead>\n \n Pain<\/strong><\/td>\n Osteoarthritis and other musculoskeletal disease; dental disease<\/td>\n<\/tr>\n \n Sensory loss<\/strong><\/td>\n Vision loss, hearing loss, other sensory decline<\/td>\n<\/tr>\n \n Endocrine<\/strong><\/td>\n Hypothyroidism, Cushing’s disease, diabetes mellitus, parathyroid disorders<\/td>\n<\/tr>\n \n Cardiovascular<\/strong><\/td>\n Systemic hypertension, cardiovascular disease<\/td>\n<\/tr>\n \n Kidney \/ liver<\/strong><\/td>\n Chronic kidney disease, liver disease<\/td>\n<\/tr>\n \n Urinary<\/strong><\/td>\n Urinary tract infection, incontinence, prostatic disease<\/td>\n<\/tr>\n \n Neurologic \/ structural<\/strong><\/td>\n Brain tumor, vestibular syndrome<\/td>\n<\/tr>\n \n Other systemic<\/strong><\/td>\n Cancer, gastrointestinal disease, skin disease<\/td>\n<\/tr>\n \n Medication effects<\/strong><\/td>\n Corticosteroids, benzodiazepines, anticonvulsants<\/td>\n<\/tr>\n \n Primary behavior problems<\/strong><\/td>\n Separation anxiety, fear-related aggression<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n ![\"Grid](\"https:\/\/wewellinfo.com\/us\/wp-content\/uploads\/2026\/08\/body-3-13.png\")
<\/p>\nPain is the one that fools everyone<\/h3>\n
What a rule-out visit actually looks like<\/h3>\n
The DISHAA signs \u2014 what to write down before the appointment<\/h2>\n
\n
Why the night pacing is usually what families notice first<\/h2>\n
What the evidence actually supports<\/h2>\n
Environment, routine and night-time safety<\/h3>\n
\n
![\"A](\"https:\/\/wewellinfo.com\/us\/wp-content\/uploads\/2026\/08\/body-4-13.jpg\")
<\/p>\nEnrichment and scent work \u2014 what the study really showed<\/h3>\n
![\"A](\"https:\/\/wewellinfo.com\/us\/wp-content\/uploads\/2026\/08\/body-5-8.jpg\")
<\/p>\nDiet and supplements \u2014 where the evidence actually sits<\/h3>\n
Medication \u2014 generic names only<\/h3>\n
The 2026 screening schedule<\/h2>\n
\n
![\"Card](\"https:\/\/wewellinfo.com\/us\/wp-content\/uploads\/2026\/08\/body-6-4.png\")
<\/p>\n![\"A](\"https:\/\/wewellinfo.com\/us\/wp-content\/uploads\/2026\/08\/body-7-8.jpg\")
<\/p>\nThe part nobody warns you about: the toll on you<\/h2>\n
When it isn’t dementia \u2014 signs that need prompt care<\/h2>\n
\n
\n
\nReferences<\/h3>\n
\n